Amgen Inc. (BVMF:AMGN34)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of BRL 954.12 billion. The enterprise value is 1.20 trillion.

Market Cap	954.12B
Enterprise Value	1.20T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 19, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.32%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.56 and the forward PE ratio is 15.63.

PE Ratio	25.56
Forward PE	15.63
PS Ratio	4.98
PB Ratio	18.61
P/TBV Ratio	n/a
P/FCF Ratio	15.52
P/OCF Ratio	13.64
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.36, with an EV/FCF ratio of 19.46.

EV / Earnings	32.05
EV / Sales	6.20
EV / EBITDA	13.36
EV / EBIT	19.97
EV / FCF	19.46

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	6.85M
Profits Per Employee	1.33M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 6.60 billion in taxes.

Income Tax	6.60B
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by +8.93% in the last 52 weeks. The beta is 0.45, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+8.93%
50-Day Moving Average	62.18
200-Day Moving Average	59.34
Relative Strength Index (RSI)	50.76
Average Volume (20 Days)	522

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.55

Income Statement

In the last 12 months, Amgen had revenue of BRL 191.70 billion and earned 37.33 billion in profits. Earnings per share was 68.93.

Revenue	191.70B
Gross Profit	134.29B
Operating Income	59.48B
Pretax Income	43.94B
Net Income	37.33B
EBITDA	87.83B
EBIT	59.48B
Earnings Per Share (EPS)	68.93

Balance Sheet

The company has 50.34 billion in cash and 290.92 billion in debt, with a net cash position of -240.58 billion.

Cash & Cash Equivalents	50.34B
Total Debt	290.92B
Net Cash	-240.58B
Net Cash Per Share	n/a
Equity (Book Value)	51.26B
Book Value Per Share	95.20
Working Capital	32.48B

Cash Flow

In the last 12 months, operating cash flow was 69.95 billion and capital expenditures -8.46 billion, giving a free cash flow of 61.50 billion.

Operating Cash Flow	69.95B
Capital Expenditures	-8.46B
Free Cash Flow	61.50B
FCF Per Share	n/a

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 1.27, which amounts to a dividend yield of 2.02%.

Dividend Per Share	1.27
Dividend Yield	2.02%
Dividend Growth (YoY)	6.16%
Years of Dividend Growth	12
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	1.74%
Earnings Yield	3.91%
FCF Yield	6.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	28

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7